ImmunoGen (United States)
In research, ImmunoGen (United States) stands highest in Medicine (#6,841 of 17,978 worldwide) and Health Sciences (#9,041 of 20,462 worldwide), over all time.
- World rank, all time
- #14,947 of 42,892
- Rank in United States
- #3,270 of 8,685
- Research works
- 305 ▼ 22% vs 2013–17
- Citations
- 18k 57.8 per fractional work
- Top-10% rate
- 32.1% record average 16.5%
- Open access
- 24% world 28%
What is ImmunoGen (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #6,841 of 17,978 | 30.0% | 188 | |
| Health SciencesDomain | #9,041 of 20,462 | 30.0% | 189 |
Each strip is that field’s whole ranked pool, with the notch where ImmunoGen (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at ImmunoGen (United States)?
Ranked on the composite score, John M. Lambert, Rajeeva Singh and Ravi Chari lead among researchers whose main affiliation is ImmunoGen (United States).
- 1 John M. Lambert United States · #94,250 worldwide 240 citations · 28 works
- 2 Rajeeva Singh United States · #207,528 worldwide 69 citations · 22 works
- 3 Ravi Chari United States · #223,572 worldwide 104 citations · 23 works
- 4 Thomas A. Keating United States · #265,730 worldwide 273 citations · 16 works
- 5 Michael Method United States · #270,535 worldwide 85 citations · 19 works
- 6 Robert J. Lutz United States · #317,161 worldwide 122 citations · 32 works
- 7 Victor S. Goldmacher United States · #558,174 worldwide 81 citations · 17 works
- 8 Erin K. Maloney United States · #622,805 worldwide 97 citations · 21 works
- 9 Michael L. Miller United States · #854,823 worldwide 61 citations · 33 works
- 10 Peter U. Park United States · #886,186 worldwide 40 citations · 19 works
Which keywords describe research at ImmunoGen (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Breast Cancer, Monoclonal Antibodies, Therapeutic Antibodies, Monoclonal Antibody, Antibody Engineering and Fc Receptors.
- Anticancer Drugs
- Rituximab
- Medicinal Chemistry
- Recombinant Proteins
- Prognostic Factors
- Chimeric Antigen Receptor
- Leukemia
- Immunotoxin
- Cancer Immunotherapy
- Radiopharmaceuticals
- Cancer Treatment
- Synthesis
- Immunotherapy
- PET Imaging
- Targeted Therapy
- Metastatic
- Fc Receptors
- Monoclonal Antibody
- Monoclonal Antibodies
- Glycosylation
- Chemotherapy
- Breast Cancer
- Therapeutic Antibodies
- Antibody Engineering
- HER2
- Trastuzumab
- Cancer Therapy
- Cancer
- Lymphoma
- Biological Evaluation
- Radioimmunotherapy
- Tumor Regression
- Metastatic Breast Cancer
- Ricin Poisoning
- CAR T Cells
- Biopharmaceuticals
- Angiogenesis
- Tumor Microenvironment
- Anticancer Agents
- Cell Cycle Control
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy64▲ 30×12 topics
- Glycosylation60▲ 89×3 topics
- Breast Cancer57▲ 67×4 topics
- Monoclonal Antibodies57▲ 130×3 topics
- Therapeutic Antibodies56▲ 142×2 topics
- Monoclonal Antibody53▲ 250×2 topics
- Antibody Engineering53▲ 173×1 topic
- Fc Receptors53▲ 173×1 topic
- HER252▲ 560×1 topic
- Metastatic52▲ 269×2 topics
- Trastuzumab52▲ 397×1 topic
- Targeted Therapy23▲ 35×5 topics
- Cancer Therapy21▲ 11×12 topics
- PET Imaging19▲ 29×4 topics
- Cancer16▲ 3.8×20 topics
- Immunotherapy14▲ 6.9×11 topics
- Lymphoma13▲ 30×3 topics
- Synthesis12▲ 7.0×8 topics
- Biological Evaluation12▲ 31×4 topics
- Cancer Treatment11▲ 14×2 topics
- Radioimmunotherapy11▲ 93×1 topic
- Radiopharmaceuticals11▲ 93×1 topic
- Tumor Regression11▲ 42×2 topics
- Cancer Immunotherapy11▲ 25×2 topics
- Metastatic Breast Cancer10▲ 49×2 topics
- Immunotoxin10▲ 100×1 topic
- Ricin Poisoning10▲ 100×1 topic
- Leukemia10▲ 48×2 topics
- CAR T Cells10▲ 72×1 topic
- Chimeric Antigen Receptor10▲ 72×1 topic
- Biopharmaceuticals9▲ 44×3 topics
- Prognostic Factors9▲ 6.5×9 topics
- Angiogenesis9▲ 7.1×7 topics
- Recombinant Proteins8▲ 52×2 topics
- Tumor Microenvironment8▲ 7.6×6 topics
- Medicinal Chemistry7▲ 6.4×7 topics
- Anticancer Agents7▲ 8.9×5 topics
- Rituximab7▲ 14×2 topics
- Cell Cycle Control7▲ 86×2 topics
- Anticancer Drugs6▲ 49×2 topics
Which research topics does ImmunoGen (United States) publish most on?
By volume in 2022–2025: HER2/EGFR in Cancer Research, Ovarian cancer diagnosis and treatment, Advanced Breast Cancer Therapies and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HER2/EGFR in Cancer Research Oncology 2 works
- 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
- 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 5 CAR-T cell therapy research Oncology 1 works
- 6 Folate and B Vitamins Research Rheumatology 1 works
- 7 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 8 Cytomegalovirus and herpesvirus research Epidemiology 0 works
- 9 Virus-based gene therapy research Genetics 0 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ImmunoGen (United States)'s research output changed?
Output in 2018–2022 was 22% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Waltham
- Brandeis University
- Bentley University
- PerkinElmer (United States)
- Thermo Fisher Scientific (United States)
- Education Development Center
- Foster-Miller (United States)
- Boston Engineering (United States)
- Fresenius Medical Care (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.